Additionally, this technology could be applied to COL4A1-related disorders, such as small vessel brain disease, porencephaly, and HANAC syndrome, by facilitating precise correction of pathogenic variants in the COL4A1 gene, thereby restoring basement membrane integrity and reducing vascular fragility. Here, COL4A1 is linked to porencephaly.